These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 29159053
1. Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET. Anazodo UC, Finger E, Kwan BYM, Pavlosky W, Warrington JC, Günther M, Prato FS, Thiessen JD, St Lawrence KS. Neuroimage Clin; 2018; 17():405-414. PubMed ID: 29159053 [Abstract] [Full Text] [Related]
2. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SCJ, van Berckel BNM, Ossenkoppele R, Barkhof F, Larsson EM. Eur Radiol; 2017 Oct; 27(10):4237-4246. PubMed ID: 28374078 [Abstract] [Full Text] [Related]
3. Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis. Haidar H, Majzoub RE, Hajeer S, Abbas LA. BMC Neurol; 2023 Oct 24; 23(1):385. PubMed ID: 37875879 [Abstract] [Full Text] [Related]
4. Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of dementia. Ceccarini J, Bourgeois S, Van Weehaeghe D, Goffin K, Vandenberghe R, Vandenbulcke M, Sunaert S, Van Laere K. Eur J Nucl Med Mol Imaging; 2020 Aug 24; 47(9):2142-2154. PubMed ID: 31960098 [Abstract] [Full Text] [Related]
5. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? Verfaillie SC, Adriaanse SM, Binnewijzend MA, Benedictus MR, Ossenkoppele R, Wattjes MP, Pijnenburg YA, van der Flier WM, Lammertsma AA, Kuijer JP, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. Eur Radiol; 2015 Oct 24; 25(10):3050-9. PubMed ID: 25899416 [Abstract] [Full Text] [Related]
6. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA. Alzheimers Dement; 2012 Jan 24; 8(1):51-9. PubMed ID: 22018493 [Abstract] [Full Text] [Related]
7. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease. Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, Pasquier F, Delmaire C. J Neuroimaging; 2016 Jan 24; 26(2):207-12. PubMed ID: 26031943 [Abstract] [Full Text] [Related]
8. Concordance of regional hypoperfusion by pCASL MRI and 15O-water PET in frontotemporal dementia: Is pCASL an efficacious alternative? Ssali T, Narciso L, Hicks J, Liu L, Jesso S, Richardson L, Günther M, Konstandin S, Eickel K, Prato F, Anazodo UC, Finger E, St Lawrence K. Neuroimage Clin; 2022 Jan 24; 33():102950. PubMed ID: 35134705 [Abstract] [Full Text] [Related]
19. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series. Moodley KK, Perani D, Minati L, Della Rosa PA, Pennycook F, Dickson JC, Barnes A, Contarino VE, Michopoulou S, D'Incerti L, Good C, Fallanca F, Vanoli EG, Ell PJ, Chan D. J Alzheimers Dis; 2015 May 24; 46(3):639-53. PubMed ID: 26402512 [Abstract] [Full Text] [Related]
20. Dose Reduction in Brain [18F]FDG PET/MRI: Give It Half a Chance. Soret M, Piekarski E, Yeni N, Giron A, Maisonobe JA, Khalifé M, Zaslavsky C, Bertaux M, Habert MO, Kas A. Mol Imaging Biol; 2020 Jun 24; 22(3):695-702. PubMed ID: 31286349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]